Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE backs Novartis’ Aimovig for prevention of episodic and chronic migraine

December 11, 2020
Medical Communications, Sales and Marketing Aimovig, NICE, Novartis, migraine

NICE has announced its decision to recommended Novartis’ Aimovig (erenumab) for the prevention of migraine, including both episodic and chronic …

News
data_security

Hackers breach EMA server to steal data on Pfizer/BioNTech’s COVID-19 vaccine

December 10, 2020
Research and Development COVID-19, EMA, Vaccine

Pfizer and BioNTech’s jointly-developed COVID-19 vaccine, which this week began to rolled out to elderly patients in the UK after …

News

NICE authorises Takeda’s Alunbrig for ALK-positive advanced non-small cell lung cancer

December 10, 2020
Sales and Marketing ALK-positive advanced non-small cell lung cancer, Alunbrig, NICE, Takeda

NICE has published its final appraisal of Takeda’s Alunbrig (brigatinib), recommending the therapy for the treatment of ALK-positive advanced non-small …

News
injection

UAE reveals 86% effiacy for Sinopharm’s COVID-19 vaccine

December 10, 2020
Research and Development COVID-19, Sinopharm, UAE, Vaccine

The Health Ministry of the United Arab Emirates has unveiled the first known efficacy data for the COVID-19 vaccine candidate …

News
lilly_entrance_web

Lilly’s tirzepatide generates significant reductions in weight and blood sugar in type 2 diabetes patients

December 10, 2020
Research and Development Eli Lilly, diabetes, tirzepatide

Eli Lilly has announced new data for its glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide, showing …

News
abbvie_0

AbbVie unveils new Phase 3 upadacitinib data in moderate to severe ulcerative colitis

December 10, 2020
Research and Development AbbVie, upadacitinib

AbbVie has announced data from the first of two Phase 3 studies investigating the efficacy of upadacitinib in treating moderate …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

December 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Top 5, pharma

COVID-19 vaccine news continues to roll in and continues to be positive, with AstraZeneca now releasing Phase 3 data that …

News

Novartis’ Kisqali delays need for chemo by over 4 years in post-menopausal HR+HER2- metastatic breast cancer

December 9, 2020
Research and Development Kisqali, Novartis, breast cancer

Novartis has lifted the curtain on updated Phase 3 data for Kisqali (ribociclib) in the treatment of hormone receptor positive, …

News
img_4190-e1376666350337-web

MHRA warns patients with history of significant allergic reactions not to receive Pfizer/BioNTech COVID-19 vaccine

December 9, 2020
Research and Development COVID-19, MHRA, UK, Vaccine

While the rolling out of Pfizer and BioNTech’s COVID-19 in the UK this week marked a historic moment in a …

News
astrazeneca_plaque

AstraZeneca and Oxford Uni vaccine is safe and effective in preventing COVID-19 infection, Phase 3 data show

December 9, 2020
Research and Development AstraZeneca, COVID-19, Vaccine

The latest efficacy data on the COVID-19 vaccine developed by AstraZeneca in partnership with the University of Oxford have been …

News
shutter

Amryt’s Lojuxta approved in Brazil to reduce cholesterol in homozygous familial hypercholesterolaemia patients

December 9, 2020
Research and Development, Sales and Marketing Amryt, Brazil, rare disease

Brazil’s National Health Surveillance Agency (ANVISA) has moved to authorise Amryt’s Lojuxta (lomitapide) in the country as a treatment for …

News
credit_nhs_england

UK launches COVID-19 vaccination drive with first dosings of Pfizer/BioNTech’s candidate

December 8, 2020
Manufacturing and Production, Sales and Marketing COVID-19, UK, Vaccine

The first doses of Pfizer and BioNTech’s approved COVID-19 vaccine have been administered in the UK in a historic occasion …

News
astrazeneca_sign_sky

NICE recommendation for AstraZeneca’s Calquence in chronic lymphocytic leukaemia populations

December 8, 2020
Manufacturing and Production, Sales and Marketing AstraZeneca, NHS, NICE, UK, leukaemia

The National Institute for Health and Care Excellence (NICE) has recommended that AstraZeneca’s Calquence (acalabrutinib) be used on the NHS in …

News
shutterstock_512649

US pharma lobby launches legal action against the Trump administration over drug pricing proposals

December 8, 2020
Manufacturing and Production, Sales and Marketing Drug pricing, PhRMA, Trump, US

US industry organisations including the Pharmaceutical Research and Manufacturers of America (PhRMA) have launched legal action against the Trump administration …

News
shutterstock_273326141

South Korea secures enough COVID-19 vaccine doses for 44 million citizens

December 8, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Vaccine, south korea

The South Korean Government has announced plans to secure enough COVID-19 vaccine doses to inoculate 44 million of its citizens, …

News
takeda_usa_pharmaceuticals_u

China approves Takeda’s Takhzyro to prevent hereditary angioedema attacks in patients over 12

December 8, 2020
Manufacturing and Production, Sales and Marketing China, Takeda

China’s National Medical Products Administration (NMPA) has given approval in the country for Takeda’s Takhzyro (lanadelumab), in a subcutaneous injection …

News
kymriah

Novartis unveils new multi-trial data for CAR-T therapy Kymriah in advanced lymphoma

December 7, 2020
Research and Development, Sales and Marketing CAR-T, Kymriah, Novartis

Novartis has taken the opportunity at the 2020 American Society of Hematology Annual Meeting & Exposition (ASH) to unveil promising …

News
europe-1395916_640

EMA receives filing for Janssen’s twice-yearly schizophrenia jab

December 7, 2020
Sales and Marketing EMA, Janssen, schizophrenia

The European Medicines Agency (EMA) has received Janssen’s Marketing Authorisation Extension for paliperidone palmitate six-monthly (PP6M), an injectable therapy administered …

News
shutterstock_38078521

Jakafi outperforms best available therapy in steroid-refractory/dependent chronic graft-versus-host disease

December 7, 2020
Research and Development, Sales and Marketing Incyte, Jakafi, Novartis

The first Phase 3 findings have been revealed for Jakafi (ruxolitinib) in the treatment of steroid-refractory or steroid-dependent chronic graft-versus-host disease …

News
janssen_latest_logo_on_sign_closer

Six-year follow-up data shows Imbruvica’s benefit in high-risk chronic lymphocytic leukaemia

December 7, 2020
Research and Development, Sales and Marketing Janssen, chronic lymphocytic leukaemia, imbruvica

Janssen has revealed multiple pooled data analyses for its Bruton’s tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib) in the first-line treatment …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025